Beginning Cash: The amount of cash reported by the company on its previous statement.
Radiopharm Theranostics Limited - Sponsored ADR (RADX) had Beginning Cash of $19.11M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$30.22M |
|
$0.03M |
|
$29.62M |
|
$59.85M |
|
$10.04M |
|
-- |
|
$17.02M |
|
$27.06M |
|
$32.78M |
|
$3.19M |
|
$32.78M |
|
11.81M |
|
| Cash Flow Statement Financials | |
$-14.88M |
|
$-3.49M |
|
$21.95M |
|
|
Beginning Cash |
$19.11M |
$22.66M |
|
$3.54M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|